By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adenosine Therapeutics, LLC (Acquired by Parexel International) 

Press releases archived for reference only.
P.O. Box 4632
Charlottesville  Virginia  22905  U.S.A.
Phone: n/a Fax: n/a



Company News
Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent 4/1/2013 10:50:55 AM
Clinical Data Acquires Adenosine Therapeutics 8/5/2008 6:45:53 AM
Adenosine Therapeutics Announces Election of Dr. Jonathan Sackier as Company Chairman and Dr. H. Jeffrey Leighton as Vice Chairman 11/13/2007 10:36:24 AM
Adenosine Therapeutics Announces Appointment of Drs. Jonathan Sackier and Steven Tregay to the Board of Directors 6/25/2007 11:28:20 AM
Adenosine Therapeutics Awarded Phase II SBIR Grant To Treat Asthma And STTR Grant To Develop New Treatment For Sepsis 10/26/2006 10:36:47 AM
Adenosine Therapeutics Initiates Phase Ib Clinical Study With ATL146e 10/25/2006 10:50:33 AM
Adenosine Therapeutics Awarded SBIR Grant To Develop New Compounds For The Treatment Of Parkinson's Disease10/19/2005 5:12:46 PM
Adenosine Therapeutics Announces $3.5 Million In Funding10/19/2005 5:12:32 PM
Adenosine Therapeutics Announces Collaboration With Ortho-McNeil Pharmaceutical, Inc. To Develop Novel Oral Drugs For Diabetes And Asthma10/19/2005 5:12:24 PM
National Institutes of Health (NIH) Awards Adenosine Therapeutics Phase II SBIR Grant To Develop New Drug Eluting Stent To Prevent Restenosis 10/19/2005 5:12:22 PM